Recent Company News

• 09:44 PM ET Jul 28, 2026
  

  StreetAccount Summary - Trading higher/lower: Australia & New Zealand midday

• 06:45 PM ET Aug 11, 2026
  

  USPTO grants composition of matter patent for Alterity Therapeutics' ATH434 to at least 2045 (A$0.54, 0.00)

• 04:46 PM ET Aug 11, 2026
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 02:03 PM ET Aug 11, 2026
  

  Transcript Intelligence: Alterity Therapeutics at Canaccord Genuity Growth Conference

• 08:29 AM ET Aug 11, 2026
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 07:05 AM ET Aug 11, 2026
  

  Alterity Therapeutics initiated buy at Craig-Hallum Capital ($4.55, 0.00)

• 08:02 PM ET Jul 29, 2026
  

  Alterity Therapeutics reports Q4 net cash from / (used in) operating activities (A$7.2M) - Appendix 4C (A$0.51, 0.00)